Mineralocorticoid receptor antagonist pretreatment to MINIMISE reperfusion injury after ST-elevation myocardial infarction (the MINIMISE STEMI Trial): rationale and study design.
about
Design of the Magnetic Resonance Imaging Evaluation of Mineralocorticoid Receptor Antagonism in Diabetic Atherosclerosis (MAGMA) Trial.Aldosterone Antagonist Therapy and Mortality in Patients With ST-Segment Elevation Myocardial Infarction Without Heart Failure: A Systematic Review and Meta-analysis
P2860
Mineralocorticoid receptor antagonist pretreatment to MINIMISE reperfusion injury after ST-elevation myocardial infarction (the MINIMISE STEMI Trial): rationale and study design.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Mineralocorticoid receptor ant ...... ): rationale and study design.
@ast
Mineralocorticoid receptor ant ...... ): rationale and study design.
@en
Mineralocorticoid receptor ant ...... ): rationale and study design.
@en-gb
type
label
Mineralocorticoid receptor ant ...... ): rationale and study design.
@ast
Mineralocorticoid receptor ant ...... ): rationale and study design.
@en
Mineralocorticoid receptor ant ...... ): rationale and study design.
@en-gb
prefLabel
Mineralocorticoid receptor ant ...... ): rationale and study design.
@ast
Mineralocorticoid receptor ant ...... ): rationale and study design.
@en
Mineralocorticoid receptor ant ...... ): rationale and study design.
@en-gb
P2093
P2860
P50
P356
P1433
P1476
Mineralocorticoid receptor ant ...... ): rationale and study design.
@en
P2093
Alamgir Kabir
Alex Sirker
Anthony Mathur
Arvindra Krishnamurthy
Cono Ariti
Daniel J Blackman
Georg M Fröhlich
Gerald J Clesham
Jeremy W Sayer
John P Greenwood
P2860
P304
P356
10.1002/CLC.22401
P577
2015-05-01T00:00:00Z